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CytotoxicityThe biological signiﬁcance of protective CD8 T-cell-mediated responses against non-traditional alternative
reading frame epitopes remains relatively unknown. Cytolytic CD8 T cells (CTL) speciﬁc for a non-traditional
cryptic MHC class I epitope, SYNTGRFPPL, are critically involved in the protection of mice during infection
with the LP-BM5 murine retrovirus. The goal of this study was to determine the functional properties of the
protective SYNTGRFPPL-speciﬁc CTL during LP-BM5 infection of susceptible BALB/c CD8−/− mice. Direct
infection experiments and adoptive transfer of CD8 T cells derived from perforin (pfp)−/−, IFNγ−/−, FasL−/−
and, as a positive control, wild-type BALB/c mice, were utilized to assess the effector mechanisms
responsible for protection. Our results indicate that SYNTGRFPPL-speciﬁc effector CTL preferentially utilize
perforin-mediated cytolysis to provide protection against LP-BM5-induced pathogenesis, whereas CTL
production of IFNγ is not required. Our results also suggest a minimal contribution of FasL/Fas-mediated lysis
during the effector response. Collectively, these results provide insight into effector mechanisms utilized by
protective CTL directed against non-traditional cryptic epitopes during disease protection.© 2009 Elsevier Inc. All rights reserved.IntroductionClearance and subsequent protection against many viral pathogens
are often mediated by the effector functions of activated cytolytic CD8 T
cells (CTL) capable of antigen-mediated cytokine secretion and directed
cytolysis of virally infected cells. Early studies using perforin-deﬁcient
mice indicated that upon engagement of the T-cell receptor, activated
CTL could trigger apoptosis in target cells through one of two distinct
molecular mechanisms (Kagi et al., 1994a, 1994b; Walsh et al., 1994a,
1994b): the granule exocytosis pathway involving directed release of
cytoplasmic granules containing pore-forming perforin and granzymes
into the target cell, or via upregulation of Fas ligand (CD95L), facilitating
binding to theFas receptor (CD95)expressedupon target cells. Initially it
washypothesized that CTLpreferentially utilized theperforin/granzyme
exocytosis pathway during infectionwith non-cytolytic viruses, such as
during acute LCMV infection in mice. What has become apparent is that
CTL have the capability to utilize multiple effector mechanisms to
eliminate/control viral infection.One Rope Ferry Road, Hanover
.R. Green).
ll rights reserved.In addition to alternative FasL-mediated cytolysis (Kagi and
Hengartner, 1996; Kagi et al., 1995), secretion of inﬂammatory
cytokines such as IFNγ and TNFα by effector CTL has also been
shown to contribute to the protective CD8-mediated immune
response, through inhibition of viral protein expression, recruitment
of antigen presenting cells (APC), and/or upregulation of MHC
expression on the surface of infected cells and APC, resulting in the
consequent increased activation of effector CD8 T cells (Guidotti and
Chisari, 2001; Harty et al., 2000). Indeed, during infectionwith acutely
cytopathic viruses – such as vaccinia, vesicular stomatitis virus,
Semliki Forest virus or inﬂuenza – it has been reported that CTL
mediate anti-viral responses through secretion of cytokines, rather
than through perforin or FasL/Fas-mediated cytolysis (Kagi and
Hengartner, 1996; Kagi et al., 1995).
In the absence of either, but not both, of the perforin- or FasL-
mediated cytolytic pathways, effector CTL effectively controlled primary
inﬂuenza infection (Topham et al., 1997). Studies in other viral systems
have also demonstrated similar cytolytic “ﬂexibility”. During the acute
phase of Friend virus infection, when virus levels have peaked, perforin
and granzymes A and B are utilized by CTL to mediate virus clearance
(Zelinskyy et al., 2004), whereas during a low-level Friend infection,
FasL/Fas interactions seem to be required for effective anti-viral CTL
responses (Zelinskyy et al., 2007). Virus clearance during pulmonary
infectionwith murine gammaherpesvirus is also mediated through CTL
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Usherwood et al., 1997). However, CD8 T-cell clearance of intestinal
rotavirus infection in adult mice was shown to be independent of not
only perforin or FasL/Fas cytotoxicity, but also secretion of IFNγ (Franco
et al., 1997), suggesting that alternative CTL mechanisms are utilized
within the mouse intestine during this viral infection. Thus, virus type,
anatomical location of infection, and level of viral infection may be
factors that inﬂuence the effector mechanisms utilized by CD8 T cells
during the anti-viral response.
Interaction between the effector CD8 T-cell receptor (TCR) and an
MHC class I molecule complexed with an 8–11 amino acid peptide
epitope is required to trigger the cytolytic and/or cytokine-mediated
effector mechanisms of CD8 T cells during infection. Historically,
peptide epitopes were automatically assumed to be derived from the
primary open reading frame of the pathogen's genome, while the rare
expression of cryptic epitopes was generally considered to be
immunologically insigniﬁcant. However, evidence has accumulated
demonstrating that CTL are able to recognize and respond to cryptic
antigens using a murine model of leukemia (Uenaka et al., 1994) and
during infection of mice with inﬂuenza (Elliott et al., 1996). To our
knowledge, our lab, utilizing the murine retrovirus LP-BM5, the
causative agent of murine AIDS (MAIDS), was the ﬁrst to deﬁne a CD8
CTL-deﬁned major immunodominant cryptic epitope in a retroviral
system (Mayrand et al., 1998, 2000; Schwarz and Green, 1994). This
LP-BM5 cryptic epitope, SYNTGRFPPL, was encoded in an alternative
reading frame (ARF) of the retroviral gag gene, apparently by a frame-
shifting mechanism(s) (Mayrand et al., 1998). Despite the increasing
evidence that cryptic peptide epitopes contribute signiﬁcantly to
effector CTL responses against tumors and viruses (Bain et al., 2004;
Basu et al., 2004; Chen et al., 2001, 2003; Ho and Green, 2006b;
Mayrand et al., 1998, 2000), there is a relative lack of information
available detailing the functional features of CTL speciﬁc for these
unique antigens.
Although CD8 T-cell effector responses appear to be critical for the
control of retroviral infections such as HIV-1, it is well documented
that recognition of HIV-1 dominant epitopes by epitope-speciﬁc CTL
drives the generation of virus escape mutants (Borrow et al., 1997;
Geels et al., 2003; Goulder et al., 1997, 2001a, 2001b; Price et al., 1997).
The ability of retroviruses to escape CD8 T-cell mediated cytotoxicity
has made the design of a protective or therapeutic vaccine quite
challenging. Cryptic epitopes represent a relatively underappreciated
reservoir of immunogenic antigens when considering the design of
multi-epitope vaccines that are intended to reinvigorate the protective
CD8 CTL response in patients with progressive AIDS (Schirmbeck et al.,
2005; Yokomaku et al., 2004). Indeed, the generation of immuno-
logically relevant cryptic epitopes during natural HIV-1 infection in
humans has recently been demonstrated. Following in vitro recognition
of synthetic peptides derived from epitopes located within ARFs of the
gag, pol, and env genes of HIV-1, CD8 T cells isolated from HIV-1
infected individuals were able to produce IFNγ and were highly lytic
towards APC pulsed with the cryptic epitopes, indicating natural in vivo
priming to these ARF-encoded determinants (Cardinaud et al., 2004).
Additionally, there was a high degree of intra- and inter-clade
conservation of these ARF epitopes amongst various isolates of the
HIV-1 virus, demonstrating that functional preservation of the protein
encoded by the primary reading frame may ultimately drive the
conservation of ARF epitopes within the genome (Cardinaud et al.,
2004).
Similar to CD8 CTL responses in HIV, such CTL-driven immune
selection of virus escape mutants has also been observed during
infection of primates with SIV (Allen et al., 2000; Barouch et al., 2002;
Evans et al., 1999), and following passage of murine retrovirus LP-BM5
in MAIDS-susceptible B6 mice (Gaur and Green, 2003). Detailed
sequence comparisons of the LP-BM5 BM5eco cloned retroviral
genome to its progenitor murine retrovirus revealed amino acid
substitutions only in the known H-2b restricted epitopes, resulting indiminished CD8 T-cell mediated immunity to LP-BM5 in B6 mice
(Gaur and Green, 2003). Further analogous to HIV infection in humans
and our system of LP-BM5 infection in mice, signiﬁcant CD8 effector
responses directed against cryptic epitopes in the SIV retroviral
infection model have also been reported. Elite (i.e. infrequent)
controllers of the SIVmac239 retroviral isolate were found to have
dominant CTL responses against a cryptic epitope located within the
+2 ORF of the gag gene (Maness et al., 2007), suggesting that, at least
for certain MHC haplotypes, protection against this retrovirus-
induced immunodeﬁciency may require CTL recognition of cryptic
ARF antigens.
Although studies with HIV and SIV cryptic antigens have provided
evidence that CD8 T cells are able to mount dominant effector
responses against cryptic antigens, there has been little direct insight
into whether these responses result in protection against virus-
induced disease. Previously, we have reported that CD8 CTL directed
against the cryptic epitope SYNTGRFPPL are sufﬁcient to induce
protection in MAIDS-susceptible BALB/c CD8−/− mice infected with
LP-BM5 retrovirus (Ho and Green, 2006b). This study directly
demonstrated that CTL recognition of cryptic epitopes in vivo resulted
in protection against retrovirus-induced pathogenesis. Due to the
similarities between HIV in humans and the disease manifestations of
MAIDS (Jolicoeur, 1991; Liang et al., 1996; Morse et al., 1992), infection
of mice with LP-BM5 represents an opportunity for a detailed and
controlled study of these unique CD8 effector T-cell responses. Our
goal was to further characterize themolecularmechanism(s) involved
in the protective CD8 T-cell response against the ARF epitope
SYNTGRFPPL during infection of MAIDS-resistant wild-type (w.t.)
BALB/c mice with LP-BM5. This question was approached both by
direct infection experiments and by utilizing the previously described
adoptive transfer approach that results in essentially full protection
against LP-BM5-induced disease when w.t. BALB/c anti-SYNTGRFPPL
effector CTL are transferred into MAIDS-susceptible CD8−/− BALB/c
mice (Ho and Green, 2006b). In particular, we employed donor BALB/
c knockout mice to approach the question of whether the perforin/
granzyme and/or FasL cytolytic pathways, and/or the production of
IFNγ, was essential for protection.
Results
Direct infection of mice deﬁcient in perforin results in enhanced
susceptibility to LP-BM5 retrovirus
Previously we have shown that resistance to LP-BM5-induced
pathogenesis in non-susceptible strains of mice, such as the BALB/c
mouse, is mediated by a protective CD8 T-cell response against a
cryptic epitope located within ORF2 of the LP-BM5 gag gene, termed
SYNTGRFPPL (Ho and Green, 2006b; Mayrand et al., 1998, 2000;
Schwarz and Green, 1994). Conventional effector mechanisms such as
perforin-mediated cytotoxicity and secretion of IFNγ are commonly
associated with enhancing the protective response during infection of
mice with Friend retrovirus (Stromnes et al., 2002; Zelinskyy et al.,
2004) and infection of humans with HIV (Benito et al., 2004).
Therefore, we initially used perforin (pfp−/−), or IFNγ (IFNγ−/−),
deﬁcient mice to determine which effector mechanisms were
involved during the CD8-mediated response against the cryptic
epitope SYNTGRFPPL during infection with LP-BM5. Activational and
immunodeﬁciency parameters associated with infection were
assessed in pfp−/− and IFNγ−/− mice and compared to disease in
susceptible BALB/c CD8−/− mice and resistant BALB/c w.t. mice.
As expected, by measurement of activational parameters such as
splenomegaly (P=.0049) and hypergammglobulinemia, with res-
pect to both IgG2A and IgM (P=.0337 and P=.0093 respectively);
in addition to measurement of immunodeﬁciency parameters,
such as impaired lymphocyte responsiveness to ConA (P=.0002),
CD8−/− mice infected with LP-BM5 had signiﬁcantly more disease
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BALB/c mice infected with LP-BM5, infection in CD8−/− mice
resulted in signiﬁcantly more splenomegaly (P=.006), serum
levels of IgG2A (P=.05) and IgM (P=.0485), and a signiﬁcantly
reduced T-cell response to ConA (P=.0144) and reduced B-cell
responses to LPS (data not shown). In direct correlation to LP-BM5
disease parameters, LP-BM5-infected CD8−/− mice had signiﬁ-
cantly greater load of viral RNA as determined by RT-qPCR analysis
for both the LP-BM5 defective and ecotropic helper viruses, as
detected in the spleen, compared to non-infected controls and
infected w.t. BALB/c mice (Fig. 1E).
Deﬁciencies in IFNγ did not result in a conversion to signiﬁcant
disease, as BALB/c IFNγ−/− mice infected with LP-BM5 had similar
spleen weights, serum levels of both IgG2A and IgM, mitogen
responsiveness to stimulation with ConA and LPS, and negligible
amounts of viral RNA present, as the non-infected control mice
(Figs. 1A–E and data not shown). These data suggested that IFNγFig. 1. Direct infection of BALB/c mice deﬁcient in perforin results in increased incidence of
were directly infected with LP-BM5 for 9 weeks, after which disease was assessed. A: Spleenw
weight for each group of animals. B: Serum levels of IgG2A and IgM immunoglobulin me
represented as the percentage counts per minute relative to the appropriate non-infected
comparison to non-infected controls, or to infected BALB/c mice. D: Disease index measure
using the non-parametric Mann–Whitney test of signiﬁcance. E: Viral RNA expression of BM5
quantiﬁed using real-time RT-PCR. Values of BM5def and BM5eco are shown as expression lev
2 experiments with N=4–9 mice/group. ⁎ indicates P≤ .05, ⁎⁎ indicates P≤ .01.was not an important effector mechanism during the protective
anti-ORF2/SYNTGRFPPL response during MAIDS pathogenesis.
However, it has been reported by others that induction of LP-BM5
pathogenesis is correlated to high levels of IFNγ: speciﬁcally that B6
mice lacking IFNγ may have reduced MAIDS disease or require a
prolonged time course to develop disease equivalent to w.t.
susceptible B6 mice (Giese et al., 1996; Morawetz et al., 1998). To
verify that the lack of disease observed in BALB/c IFNγ−/− mice
was not instead due to an IFNγ-dependent pathogenic mechanism,
we infected susceptible B6 mice lacking IFNγ with equivalent
amounts of LP-BM5 and assessed disease severity, compared to w.t.
B6 controls. With this experimental system, we found that IFNγ−/−
B6 mice had similar splenomegaly and immunosuppression as
compared to infected w.t. B6 controls (Figs. S1A and B). Thus, the
absence of disease susceptibility in BALB/c IFNγ−/− mice infected
with LP-BM5 suggested that IFNγ may not be required during the
protective response against LP-BM5-induced pathogenesis.disease following infection with LP-BM5. BALB/c, CD8−/−, pfp−/−, and IFNγ−/− mice
eights of individual mice with or without infection by LP-BM5. Bars represent themean
asured by standard ELISA. C: T-cell responsiveness to ConA stimulation. The data are
control. Students T tests were used to measure disease signiﬁcance of infected mice in
ment considering all parameters of LP-BM5-induced disease. Statistics were calculated
def and BM5eco from spleen-derived RNA samples isolated from LP-BM5-infectedmice,
els relative to values obtained for β-actin controls. The data are representative of at least
Fig. 2. FasL/Fas-mediated cytolysis does not substantially contribute to the effector activity of ORF2/SYNTGRFPPL-speciﬁc CD8 T cells. A: Lysis of L1210Fas+/− target cells, alone or
pulsed with SYNTGRFPPL peptide, was measured by titration with ORF2/SYNTGRFPPL-speciﬁc splenocytes, obtained from BALB/c, FasL−/−, or pfp−/− mice primed with DG-Vac/
SYNTGRFPPL followed by secondary restimulation of splenocytes with synthetic peptide. B: ORF2/SYNTGRFPPL-speciﬁc cytotoxicity by the highly lytic ORF2/SYNTGRFPPL-speciﬁc
CTL clone, D7, and by CTL derived from DG-Vac/SYNGRFPPL stimulated w.t. BALB/c mice. CTL activity was measured against P815B targets incubated with or without the addition of
the relatively calcium-speciﬁc chelating agent EGTA and MgCL2. The data are representative of at least 2 independent experiments. C: Disease index of CD8−/− recipients receiving
adoptive transfer of 1–3×107 puriﬁed naïve CD8 T cells isolated from FasL−/− or w.t. BALB/c mice and infected with LP-BM5. Disease was assessed at 11 weeks post-infection. NS
indicates non-signiﬁcant differences between experimental groups. Students T tests were used to measure disease signiﬁcance of infected mice in comparison to non-infected
controls, or to infected BALB/c mice.
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signiﬁcant increase in spleen weight compared to either non-infected
pfp−/− controls (P=.033) or to the w.t. BALB/c mice infected with
LP-BM5 (P=.0452) (Fig. 1A). There was a trend towards an
increased, although not signiﬁcantly greater, amount of serum
IgG2A in pfp−/− mice infected with LP-BM5 compared to non-
infected pfp−/−mice (Fig. 1B). However, it was clear that the infected
pfp−/−mice converted to disease susceptibility based on the hyper Ig
criterion, as serum levels of IgM were signiﬁcantly greater in pfp−/−
infected mice compared to the pfp−/− uninfected controls
(P=.0293). Conﬁrming a conversion to disease susceptibility in
BALB/c pfp−/− mice, T-cell responsiveness to ConA was signiﬁcantly
reduced (P=.0297) upon infection (Fig. 1C), and correspondingly,
viral load was signiﬁcantly increased compared to non-infected
controls and both infected IFNγ−/− and w.t. BALB/c mice (Fig. 1E).
Overall, summation of all disease parameters into a measurement ofdisease index clearly indicated that a deﬁciency in perforin resulted
in signiﬁcantly greater MAIDS disease compared to the disease index
of both pfp−/− non-infected controls (P=.0007), and, the disease
index of infected w.t. BALB/c mice (P=.0235) (Fig. 1D). Collectively,
these results provide evidence that the ability to express perforin is an
important factor in the resistanceofw.t. BALB/cmice to LP-BM5-induced
pathogenesis and speciﬁcally to the spread of retroviral infection.
FasL/Fas-mediated CTL mechanisms do not signiﬁcantly contribute to
the CD8 T-cell response during LP-BM5 infection
Based upon the phenotype of the FasLgldmutation, it is well known
that homozygous mutant mice develop enlarged spleens, lymphade-
nopathy, and systemic autoimmunity, with signiﬁcant onset of
symptoms by 20 weeks of age (Roths et al., 1984). In agreement
with the literature, and, despite evidence of a trend towards elevated
232 M.R. Rutkowski et al. / Virology 390 (2009) 228–238spleen weights and levels of serum IgG2A and IgM and increased
immunosuppression during infection of FasL−/− mice, non-infected
FasL−/− mice also had a signiﬁcantly greater disease index than
uninfected CD8−/− mice (Fig. S2). Based upon these data, it was
apparent that the direct infection approach could not be used to
decipher whether the FasL/Fas cytolytic pathway is involved in
reducing LP-BM5-mediated pathogenesis.
Alternatively, in order to approach the possibility that the FasL/Fas
pathway may be utilized as a cytolytic effector mechanism by
protective CTL directed against the ORF2/SYNTGRFPPL epitope, we
compared in vitro lysis of the Fas expressing, L1210Fas+, or Fas
negative, L1210Fas−, lymphocytic leukemia lines as target cells by
effector CTL, derived from Vac-DG primed w.t. BALB/c, pfp−/− or
FasL−/− mice after secondary in vitro restimulation with
SYNTGRFPPL. Roughly equivalent lysis of Fas-expressing L1210Fas+,
versus Fas-deﬁcient L1210Fas−, target cells pulsed with SYNTGRFPPLFig. 3. Phenotypic characterization of ORF2/SYNTGRFPPL effector CTL prior to transfer into CD
titrated against P815B targets pulsed with or without SYNTGRFPPL peptide. B: Antigen-speci
lymphocytes that are positive for both CD8 and expression of IFNγ. The numbers in parenthe
CD8 T cells expressing IFNγ from 2 separate experiments. C: Tetramer staining of ORF2/SY
tetramer-speciﬁc CD8 T lymphocytes. Numbers in parenthesis represent the mean, plus or mi
Kd/SYNTGRFPPL tetramer from 8 individual experiments. To control for non-speciﬁc binding
Kd/GFNKLRSTL.peptide was observed using ORF2/SYNTGRFPPL-speciﬁc effector CTL
generated from w.t. BALB/c mice (Fig. 2A), suggesting that Fas
expression on the targets was not required for SYNTGRFPPL-
mediated cytolysis in the presence of perforin. Additionally, sub-
stantial lysis of SYNTGRFPPL-pulsed L1210Fas+ and L1210Fas− target
cells was observed using effector CTL derived from FasL−/− mice
(Fig. 2A). In agreement with this data, viral load in FasL−/− mice
infected with LP-BM5 was signiﬁcantly reduced compared to that
detected in susceptible CD8−/− mice (Fig. S2). In sharp contrast, the
absence of perforin expression by the effector cells resulted in
ablation of target-cell lysis of either the Fas1210+ or Fas1210−
peptide-pulsed targets (Fig. 2A). There was, at best, a slight increase
in the lysis of Fas1210+ target cells by pfp−/− effector cells, however
this lysis did not appear to be peptide speciﬁc, as there was no dif-
ference in lysis of Fas1210+ targets pulsed with SYNTGRFPPL peptide,
compared to the mock pulsed control targets.8−/− recipients. A: Lytic activity of BALB/c, pfp−/−, or IFNγ−/− ORF2/SYNTGRFPPL CTL
ﬁc IFNγ expression of ORF2/SYNTGRFPPL CTL. Numbers indicate the total percentage of
sis represent the mean, plus or minus the standard deviation, of the total percentages of
NTGRFPPL-speciﬁc CTL. The numbers represent the total percentage Kd/SYNTGRFPPL
nus the standard deviation, of the total percentage of CD44 high CD8 Tcells stained with
of the H-2Kd tetramer, BALB/c CTL were also stained with the non-speciﬁc M2 tetramer,
Fig. 3 (continued).
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under conditions in which the perforin/granule exocytosis pathway
was inhibited by blockadewith calcium-speciﬁc chelating agent EGTA.
Lysis of SYNTGRFRPPL-pulsed P815B target cells by ORF2/SYNTGRFPPL-speciﬁc w.t. polyclonal CTL, and the cell line D7, the
highly lytic SYNTGRFPPL-speciﬁc CD8 CTL clone derived from
polyclonal BALB/c CD8 T-cell effectors of the same speciﬁcity
(Mayrand et al., 1998), was nearly abolished when EGTA was added
Fig. 4. ORF2/SYNTGRFPPL-speciﬁc effector CTL lacking perforin are unable to confer full
protection against LP-BM5-induced MAIDS in CD8−/− recipients. Mice shown were
infected with LP-BM5 as previously described. Mice received 4 transfers at 3-day
intervals consisting of approximately .6–1×107 total cells per transfer. Effector cells
from Vac-DG primed w.t. BALB/c mice, with or without prior positive selection for CD8
or CD4 T cells (pCD8+ or pCD4+) or negative selection for CD8 T cells (pCD4−)
following SYNTGRFPPL restimulation, were also transferred as controls for ORF2/
SYNTGRFPPL-speciﬁc CD8-dependent protection. Disease was measured 9 weeks
post-infection. A: Spleen weight. B: T-cell responsiveness to ConA and B-cell res-
ponsiveness to LPS stimulation. Students T tests were used to measure disease
signiﬁcance of infected CD8−/− recipients in comparison to the non-infected CD8−/−
or infected CD8−/− controls.
234 M.R. Rutkowski et al. / Virology 390 (2009) 228–238to the assay mixture (Fig. 2B), further supporting the preferential use
of perforin by protective CTL directed against the cryptic epitope
SYNTGRFPPL.
Given the report that there are limitations in utilizing the 51Cr
cytotoxicity assay to examine the FasL/Fas-mediated cytolytic path-
ways (Liu et al., 2002) and in order to verify the in vitro data, we chose
to examine CD8 effector mechanisms with FasL-deﬁcient CTL
generated in vivo. In order to diminish the pre-existing systemic
lymphoproliferative and immunosuppressive effects of FasL deﬁ-
ciency observed using the direct in vivo infection model, the genetic
effect of the FasL mutation was isolated solely to the CD8 compart-
ment. MAIDS-susceptible CD8−/− mice were reconstituted with
puriﬁed naïve CD8 T cells derived from FasL−/− or w.t. BALB/c mice.
Similar to what was observed following direct infection of BALB/c
mice, LP-BM5 infected CD8−/−mice receiving naïvew.t. BALB/c CD8 T
cells had a signiﬁcantly lower disease index than LP-BM5-infected
CD8−/− recipients that did not receive transfer of naïve CD8 T cells
(P=.0016), indicating that transfer of w.t. BALB/c CD8 T cells resulted
in sufﬁcient protection from MAIDS pathogenesis. Infected CD8−/−
mice receiving naïve FasL−/− CD8 T cells had a signiﬁcantly greater
disease index, compared to non-infected controls receiving FasL−/−
CD8 T cells (P=.011). However, in comparison to the disease index
of non-reconstituted CD8−/− mice infected with LP-BM5, FasL−/−
CD8 T cells were sufﬁciently and signiﬁcantly able to protect in-
fected CD8−/− recipients from LP-BM5-induced pathogenesis
(P=.019). Additionally, transfer of FasL−/− CD8 T cells did not result
in a signiﬁcant increase in disease index (Fig. 2C) or viral load (data not
shown) compared to CD8−/− mice receiving w.t. BALB/c CD8 T cells.
These data, taken together, indicate that cytolysis through the FasL/Fas
pathway has, at best, a minor contribution to the CTL response during
LP-BM5 infection in BALB/c mice, and that an absence of FasL in the
CD8 cellular compartment leads to perhaps partial disease in
comparison to susceptible CD8−/− mice, but not relative to CD8−/−
mice reconstituted with w.t. CD8 T cells.
Isolation of effector deﬁciencies results in the inability of perforin-,
but not IFNγ-, deﬁcient effector CD8 T cells to effectively control
LP-BM5-induced pathogenesis
Since direct infection experiments demonstrated that perforin-
deﬁcient mice are more susceptible to LP-BM5-induced pathogenesis
than w.t. BALB/c mice, we wanted to determine whether in vivo
disease susceptibility was speciﬁcally due to a defect in certain
effector-cell functional capabilities by the CD8 T cells speciﬁc for
ORF2/SYNTGRFPPL. To this end, ORF2/SYNTGRFPPL-restimulated
polyclonal effector cells derived from IFNγ−/− or pfp−/− mice
previously immunized with Vac-DG were adoptively transferred into
LP-BM5-infected CD8−/− recipients. Prior to transfer, to conﬁrm the
functional effector phenotype of transferred CTL, cytolytic capabilities,
IFNγ cytokine production, and antigen speciﬁcity were assessed.
Cytolysis of SYNTGRFPPL-pulsed P815B target cells was demonstrated
at high levels by w.t. BALB/c and IFNγ−/− effectors; however, as
expected lysis of peptide-pulsed P815B targets was not detected at
signiﬁcant levels using pfp−/− CTL as effectors (Fig. 3A). Similarly,
peptide-speciﬁc IFNγ production, while not observed by effectors
derived from IFNγ−/−mice, was robust for pfp−/− andw.t. polyclonal
effectors (Fig. 3B). Tetramer staining of the polyclonal effector cells
derived from w.t, pfp−/−, and IFNγ−/− BALB/c mice indicated that
40–50% of total CD8 T cells were similarly speciﬁc for SYNTGRFPPL,
irrespective of deﬁciencies in perforin or IFNγ (Fig. 3C).
As previously described (Ho and Green, 2006b), both activa-
tional and immunodeﬁciency readouts, measured by spleen weight
and mitogen-induced proliferation, respectively, indicated minimal
disease in CD8−/− mice reconstituted with BALB/c ORF2/
SYNTGRFPPL-speciﬁc polyclonal CTL (Figs. 4A and B), indicating
essentially complete protection from LP-BM5-induced MAIDS.Similar protection from disease was observed following infection
of CD8−/− mice subsequently reconstituted in parallel with IFNγ−/−
SYNTGRFPPL-speciﬁc CTL. However, and strikingly, reconstitution of
CD8−/− mice with pfp−/− effector CTL resulted in signiﬁcantly
greater LP-BM5-induced disease with respect to all MAIDS para-
meters: splenomegaly (Pb.01) and immunosuppression (Pb.01),
measured by lymphocyte responsiveness to both ConA and LPS,
compared to non-infected CD8−/− mice (Figs. 4A and B). In support
of previously published results (Ho and Green, 2006b) demonstrating
that CD8 effector CTL per se were responsible for mediating disease
resistance, transfer of puriﬁed CD4 T cells by positive selection just
prior to transfer (pCD4+) resulted in a similar level of disease,
compared to CD8−/− mice not receiving a transfer. Conversely,
puriﬁcation of CD8 T cells from bulk CTL cultures via either positive
selection (pCD8+) or CD4 depletion (CD4p−), also just prior to
transfer, resulted in signiﬁcant disease protection, similar to the
protection observed for the transfer of bulk CTL preparations.
Interestingly, the splenomegaly of infected CD8−/− mice receiving
pfp−/− donor cells was less severe compared to control LP-BM5-
infected, but non-reconstituted, CD8−/− mice (P=.02). These data
suggested the possibility of one or more residual pfp-independent
mechanisms of protection, and/or a differential ability to resolve the
level of disease by this, compared to the other, disease parameters.
Collectively, these ﬁndings suggest that perforin function, speciﬁcally
by ORF2/SYNTGRFPPL-speciﬁc CD8 T cells, is critical for full MAIDS
resistance.
Discussion
The essential role of CD8 T cells in protection against MAIDS, based
upon CD8 T-cell recognition of a non-traditional cryptic epitope, has
been previously demonstrated, as gag-speciﬁc CD8 CTL directed
against an epitope located within ORF2 of the gag gene are critical for
235M.R. Rutkowski et al. / Virology 390 (2009) 228–238mediating resistance to LP-BM5-induced pathogenesis (Mayrand
et al., 2000; Schwarz and Green, 1994). Reconstitution of disease
susceptible BALB/c CD8−/− mice with CD8 CTL directed against this
cryptic epitope restored resistance to virus-induced pathogenesis,
including viral immunosuppression (Ho and Green, 2006b). This
essentially complete level of protection was remarkable, considering
that the very nature of the generation of cryptic ARF-encoded epitopes
may suggest a diminished density of cell surface viral peptide-MHC
class I complex presented, in this case, on LP-BM5-infected target
cells. Consequently, either a decreased frequency of CD8 CTL capable
of recognizing these presumably infrequent antigens, and/or the
possibility that CTL generated against these epitopes may have
qualitatively and/or quantitatively impaired effector functions, may
well limit the effectiveness of CD8-driven anti-ARF epitope immune
responses. However, it has been extrapolated that target cells with an
average of three epitope-MHC-I complexes expressed upon the
surface are sufﬁcient to induce a half-maximal cytolytic response by
effector CD8 T cells (Sykulev et al., 1996), presumably due to the
selective expansion of high avidity TCR-bearing CD8 T cells (Zook et
al., 2006). It is tempting to speculate that the dominant CD8 T-cell
response against the Kd-restricted gag ARF cryptic epitope
SYNTGRFPPL arose because of an absence of functional CTL epitopes
encoded in the primary retroviral reading frames, due to immune
selection against these typical epitopes. Indeed, in the B6 strain,
passage of LP-BM5 in vivo has resulted in epitope-crippling mutations
in three of four known ORF1 epitopes (Gaur and Green, 2003).
Evolution of CD8 T-cell responses to recognize cryptic ARF epitopes is
not uncommon, as a similar effect was observed upon deletion of the
major ORF1 CTL determinant in herpes simplex virus, resulting in an
overall increase of previously undetectable CD8 T cells speciﬁc for
cryptic determinants (Wallace et al., 1999).
In this report, we studied BALB/c mice deﬁcient in effector
mechanisms associated with CD8 T-cell function, namely the
apoptosis-inducing FasL/Fas and perforin/granzyme cytolytic path-
ways, and the secretion of the anti-viral cytokine IFNγ. The results
herein indicate a conventional, albeit selective, engagement of CD8
T-cell protective mechanism(s) in response to a cryptic ARF immuno-
dominant epitope. Direct infection of mice deﬁcient in perforin, FasL,
or IFNγ, in addition to experiments involving isolation of effector
deﬁciencies to the CD8 compartment, indicated that perforin-
mediated cytolysis is the dominant effector mechanism during the
CD8-directed protective response against the ARF epitope
SYNTGRFPPL. To a lesser degree, our in vivo data suggested that
FasL/Fas signaling may contribute slightly to the effector function of
protective CD8 T cells during the anti-LP-BM5 response.
Although direct infection of FasL−/− mice with LP-BM5 suggested
a trend towards increased disease pathology, the signiﬁcant disease
susceptibility of pfp−/− mice, both by incidence and severity,
indicated that a systemic deﬁciency in perforin results in an enhanced
susceptibility to LP-BM5-induced pathogenesis (Figs. 1A–D). Suscept-
ibility in pfp−/−mice was somewhat variable, as a small proportion of
directly infected pfp−/− mice did not appear to display signiﬁcant
MAIDS pathogenesis (Fig. 1A). Additionally, CD8−/− mice receiving
adoptive transfer of ORF2/SYNTGRFPPL-speciﬁc pfp−/− CD8 CTL had
signiﬁcantly less lymphoproliferation, as measured by spleen weight,
compared to the highly susceptible CD8−/− mice infected with LP-
BM5 (Fig. 4A). However, in support of our overall conclusion that
perforin-mediated cytolysis is the dominant effector mechanism of
CTL directed against the ARF epitope SYNTGRFPPL, this reduced level
of protection was not observed for the other disease parameters,
whether tested by the adoptive transfer approach (Fig. 4) or the direct
infection approach (Fig. 1). Preferential use of perforin by CTL
resulting in incomplete protection from disease, as evidenced by
some parameters of pathogenesis, could be due to two possible, non-
exclusive mechanisms: 1) disease kinetics of splenomegaly in pfp−/−
deﬁcient mice are reduced in comparison to the highly susceptibleCD8−/− deﬁcient mice, and/or 2) SYNTGRFPPL-speciﬁc effector CTL
are polyfunctional, requiring multiple effector mechanisms to impart
full protection from disease in infected mice.
Regarding reduced disease kinetics in pfp−/− mice, a previous
study examining mechanisms in MAIDS-resistant mice suggested that
pfp deﬁciency in B10.D2 (H-2d) mice resulted in susceptibility to LP-
BM5-induced pathogenesis: e.g. about 12% developed robust disease
by 16 weeks of infection (Tang et al., 1997). Therefore, the partial
susceptibility of pfp−/−mice could putatively depend upon the stage
or level of LP-BM5 infection. Similar observations have been made
during natural HIV infection in humans (Rehr et al., 2008) or during
Friend retroviral infection of mice (Zelinskyy et al., 2004, 2007).
Polyfunctionality of SYNTGRFPPL-speciﬁc effector CTL is an additional
explanation for this varying level of disease susceptibility in pfp−/−
mice. HIV-1 patients receiving antiretroviral therapy had an increase
in polyfunctional CD8 T cells that were able to degranulate and secrete
IFNγ, TNFα, and IL-2 in response to infection, resulting in further
reduced viral loads. In contrast, in patients with high viral loads, or
prior to the establishment of antiretroviral therapy, CD8 T cells were
dysfunctional with respect to secretion of effector cytokines (Rehr et
al., 2008). During infection of mice with Friend murine retrovirus,
depending upon the level of virus replication, perforin/granzymes A
and B, or FasL/Fas-mediated cytolysis of target cells was preferentially
utilized by CTL to mediate virus clearance (Zelinskyy et al., 2004,
2007). Polyfunctional effector CD8 T cells have been documented in
several other viral systems. Using a murine model of inﬂuenza
infection, perforin-deﬁcient CD8 T cells were only able to mediate
virus clearance in the presence of Fas, demonstrating that both lytic
pathways were utilized by CTL during virus clearance (Topham et al.,
1997). Similar ﬁndings were described with murine gammaherpes-
virus (Topham et al., 2001). Alternatively, it is possible that perforin-
independent killing of target cells by granzymes A and B might
contribute to the variable susceptibility of perforin-deﬁcient mice.
Recent studies support this notion, that, in the absence of perforin,
granzymes A and B are capable of mediating cytolysis (Gondek et al.,
2005; Kurschus et al., 2004; Zelinskyy et al., 2004).
In regards to the role of IFNγ as an important effector mechanism,
we have conclusively demonstrated that IFNγ−/− CTL are effectively
able to lyse SYNTGRFPPL-pulsed target cells and that BALB/c IFNγ−/−
mice are not susceptible to LP-BM5-mediated pathogenesis. Addi-
tionally, we demonstrated by adoptive transfer and thereby localizing
the IFNγ deﬁciency to the CD8 effector cells, that BALB/c IFNγ−/− CTL
were able to mediate full protection of CD8−/− recipients infected
with LP-BM5. However, as a possible confounding effect, other reports
have proposed that IFNγ may be an important mediator of disease in
susceptible B6 mice, resulting in diminished pathogenesis in IFNγ−/−
mice. Treatment of B6 mice with neutralizing mAb to IFNγ before and
during the period of infection (Uehara et al., 1994), or utilizing B6
IFNγ−/− mice (Giese et al., 1996), was reported to signiﬁcantly delay
the progression of some, but not all, parameters of MAIDS. This notion
could be extrapolated, albeit with difﬁculty, to the context herein of
CD8−/−mice receiving IFNγ−/− effector CTL. However, during similar
experimental conditions as our direct infection of BALB/c IFNγ−/−
mice, we found that infection of B6 IFNγ−/− mice clearly resulted in
signiﬁcant splenomegaly and immunosuppression, comparable to
what was observed in w.t. B6 mice (Fig. S1). These data demonstrate,
that in our infection model of BALB/c-background knockout mouse
strains, the lack of disease observed in BALB/c IFNγ−/−mice was not
due to an effect that IFNγ had upon LP-BM5 pathogenesis per se, but
rather was explained by the observation that adoptively transferred
BALB/c IFNγ−/− CD8 T cells could impart disease protection similar to
that observed using w.t. BALB/c CTL.
This study provides an important insight into the effector
mechanisms utilized by protective CTL directed against a cryptic
epitope and further underscores the physiological signiﬁcance of ARF
epitopes in disease protection. Collectively, the ﬁndings presented
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lesser degree, FasL function, by SYNTGRFPPL-induced CD8 T cells, are
required for full MAIDS resistance. In terms of vaccination strategies
utilizing vectors that can translate from cryptic reading frames,
knowing the preferential effector mechanisms utilized by CTL to
control viral replication is crucial, as inserting additional immuno-
genic components that result in enhanced and polyfunctional effector
activity should result in a multipronged and highly effective attack on
virally infected target cells. Due to the genetic constraints associated
with encoding multiple proteins critical for viral pathogenesis and
replicationwithin overlapping reading frames of a viral genome that is
limited in size, retroviruses and many other viruses may have a
particularly low tolerance for amino acid sequence variations within
embedded cryptic ORF (or conventional ORF1) epitopes in these
regions of overlap (Ho and Green, 2006a). In support of this notion,
conservation of cryptic epitopes within the genome of HIV-1 has been
demonstrated amongst multiple isolates of circulating virus (Cardi-
naud et al., 2004). Thus, cryptic epitopes present an attractive source
of additional immunogenic determinants that may be utilized to elicit
protective CD8 T-cell responses (Ho and Green, 2006b) during
infection with viruses prone to antigenic variation due to immune
selection pressures.
Materials and methods
Mice
Female BALB/c w.t. mice (6–8weeks old) were purchased from the
National Cancer Institute (NCI, Bethesda, MD). Breeding pairs for
knockout mice on the BALB/c background were kindly provided as
follows: CD8−/− from P. Stuart (Washington University, St. Louis, MO)
and T. Mak (Ontario Cancer Institute, Toronto, Canada); FasL−/− from
W. Davidson (American Red Cross, Rockville, MD); IFNγ−/− from J.
Gorham (Dartmouth Medical School, Lebanon, NH); and Perforin −/−
mice (pfp−/−) from T. Sayers (NCI, Bethesda, MD) and M. Smyth
(Peter MacCallum Cancer Institute, Australia). Mice were bred and
housed in speciﬁc pathogen free conditions. All experimental
procedures were approved by and performed under the requirements
set forth by the AAALAC accredited Animal Care and Use Program of
Dartmouth College.
Cell lines, viruses, and reagents
The P815B mouse mastocytoma cell line (H-2d), provided by J.
Bennink (NIH/NIAID, Bethesda, MD), was maintained in RPMI 1640
supplemented with 5% fetal calf serum, 2 mM L-glutamine, 30 μg/ml
penicillin, 20 μg/ml streptomycin, and 33 μg/ml gentamicin. The
mouse lymphocytic leukemia cell lines L1210Fas− and L1210Fas+
were kindly provided by R. Dutton (Trudeau Institute) andmaintained
in DMEM supplemented with 5% fetal calf serum, 2 mM L-glutamine,
30 μg/ml penicillin, 20 μg/ml streptomycin, and 200 μg/ml gentami-
cin. The mouse anti-SYNTGRFPPL CTL line, clone D7, was generated as
previously described (Mayrand et al., 1998), maintained by restimula-
tion every two weeks with 106/ml irradiated syngeneic splenocytes
(3000 rads), and 10 μg/ml SYNTGRFPPL peptide. The LP-BM5
retroviral isolate, originally provided by J. W. Hartley and H. C.
Morse (National Institutes of Health/National Institute of Allergy and
Infectious Diseases, Bethesda, MD), was propagated in our laboratory
as previously described (Green et al., 2008; Klinken et al., 1988). Vac-
DG, the recombinant vaccinia virus with the gag gene of the LP-BM5
retrovirus inserted, was generated as previously described (Schwarz
and Green, 1994). The LP-BM5 ORF2 peptide (SYNTGRFPPL) was
purchased from Invitrogen Life Technologies at N95% purity. The
control gammaherpesvirus latent peptideM291–99 (GFNKLRSTL) was a
generous gift from E. Usherwood, at Dartmouth Medical School.
Tetramer, consisting of Kd folded with SYNTGRFPPL peptide andlabeled with allophycocyanin, was provided by the NIH Tetramer Core
Facility (Atlanta, GA). The control allophycocyanin-labeled tetramer,
consisting of Kd folded with GFNKLRSTL, was a generous gift from E.
Usherwood (Dartmouth College).
Puriﬁcation of splenocyte subpopulations
Splenocyte suspensions derived from FasL−/− or w.t. BALB/c mice,
or from BALB/c mice primed with Vac-DG, were labeled with
antibody-coupled paramagnetic beads (MACS; Miltenyi Biotec,
Auburn, CA) and subjected to column puriﬁcation according to the
manufacturer's protocol. Puriﬁcation was veriﬁed by ﬂow cytometry:
≥95% purity for CD8 enrichment, N99% for CD4 or CD8 depletion, and
≥96% purity for CD4 enrichment. For adoptive transfer experiments,
recipient CD8−/− mice were infected with LP-BM5 retrovirus 48 h
post-transfer. For in vitro restimulation, .1 μg/ml synthetic
SYNTGRFPPL peptide was added to splenocytes cultures, as detailed
below.
Infections and adoptive transfers
For all LP-BM5 infections, mice were infected intraperitoneally
with 5×104 plaque forming units (pfu). For polyclonal anti-viral CTL
generation, w.t. BALB/c or BALB/c IFNγ−/−, pfp−/−, and FasL−/−
mice were immunized i.p. with 3×107 pfu of Vac-DG as previously
reported (Ho and Green, 2006b). Brieﬂy, antigen-sensitized spleno-
cytes were isolated approximately 3 weeks post-priming: the mice
were sacriﬁced and splenocytes were collected by homogenization
through mesh screens followed by lysis of red blood cells. Splenocytes
were cultured in media with .1 μg/ml of SYNTGRFPPL peptide for
6 days. For short-term maintenance of the cultures, splenocytes were
carried for an additional 3 days with 5 U/ml of rIL-2 (Cetus
Corporation, Everyville, CA). Prior to adoptive transfer into BALB/c
CD8−/− recipients, CTL were characterized for antigen speciﬁcity by
staining with tetramer. SYNTGRFPPL-speciﬁc cytotoxicity and IFNγ
production were assessed by using the standard 51Cr release assay
(Schwarz and Green, 1994), and intracellular cytokine staining, res-
pectively. Three, 6, 9, and 12 days post LP-BM5 infection, 0.8–1.5×107
polyclonal CTL, or CTL containing approximately 5×105 ORF2/
SYNTGRFPPL-speciﬁc CTL (enumerated by tetramer staining), were
transferred intravenously into naïve or LP-BM5 infected CD8−/−
recipients. Alternatively, when indicated, approximately 1–3×107
puriﬁed naïve CD8 T cells were transferred into CD8−/− recipients.
Chromium release cytotoxicity assays
ORF2/SYNTGRFPPL-speciﬁc cytolytic activity was determined in a
standard 51Cr release assay using P815B or L1210Fas+ or L1210Fas−
cells pulsed with 200 μCi of 51Cr, followed by pulsing cells with or
without 100 ng/ml SYNTGRFPPL peptide at 37 °C for 30 min in RPMI
supplemented with 10% calf serum and 30 μg/ml penicillin, 20 μg/ml
streptomycin. Blockade of perforin-mediated cytotoxicity was
achieved by incubation of target cells in medium containing 3 mM
EGTA. In this case, to promote the interaction of effector T cells with
L1210Fas+/− target cells mediated by LFA adhesion molecules, 2 mM
MgCL2 was added to the assay medium during incubation of target
cells with effector cells.
Intracellular cytokine stain of IFNγ
ORF2/SYNTGRFPPL-speciﬁc CTL were incubated in complete
medium plus 1 μg/ml SYNTGRFPPL or control GFNKLRSTL peptides,
10 U/ml rIL-2 and 10 μg/ml brefeldin A for 6 h at 37 °C. Cultured cells
were subsequently incubated with a monoclonal antibody (mAb)
directed against the FcγII/III receptors (2.4G2, BD Pharmingen) for
10 min on ice followed by surface staining with PE Cy-5-conjugated-
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mouse CD8 (53-6.7, BD Pharmingen) for 20min on ice. Cells were then
ﬁxed in a 1% solution of paraformaldehyde for 20 min at room
temperature and rendered permeable with buffer containing .5%
saponin (Sigma) for 10 min at room temperature. After permeabiliza-
tion, cells were cytoplasmically stained with PE-conjugated-anti-
mouse IFNγ (XMG1.2, eBioscience) or isotype control mAb for 30 min
at room temperature. Stained cells were analyzed on a FACSCalibur
ﬂow cytometer using CellQuest software (BD Bioscience).Tetramer staining
ORF2/SYNTGRFPPL-speciﬁc CTL were incubated with anti-FcγII/III
on ice for 10 min. Cells were then incubated with APC-conjugated Kd/
SYNTGRFPPL tetramer or control APC-conjugated Kd/GFNKLRSTL at
room temperature for 1 h, followed by labeling with FITC-anti-CD8α
and PE-anti-CD44 for 20 min on ice. Stained cells were then analyzed
on a FACSCalibur as previously stated.LP-BM5 disease measurement
For analysis of LP-BM5-induced lymphoproliferation, spleen
weight was determined, and serum, separated from the collected
peripheral blood of sacriﬁced mice, was tested for total levels of IgG2A
and IgM in a standard ELISA assay, as previously described in detail
(Green et al., 2008; Li and Green, 2006). Immunodeﬁciency was
measured using Con A and LPS mitogen-induced proliferation assays
of isolated splenocytes as previously described (Green et al., 2008; Li
and Green, 2006). For calculation of viral load, mRNA encoding the
BM5 defective and ecotropic gag genes was ampliﬁed from puriﬁed
splenic RNA by real-time RT-PCR as previously described (Cook et al.,
2003).Calculation of disease index
Disease index was determined by calculating the % disease of all
experimental mice for each disease parameter (splenomegaly, LPS and
ConA mitogen response, and serum levels of IgG2A and IgM). Percent
diseasewas calculatedusing the formula: ((experimental value−mean
value of non-infected controls)/(mean value of LP-BM5-infected
controls−mean value of non-infected controls))×100. CD8−/− mice
were used as infected and non-infected controls. Mice with 0% or
calculated “negative” disease for any one parameter were assigned a
value of 0, mice with 1–20% disease were assigned a value of .5, mice
with 21–40% disease were assigned a value of 1, mice with 41–60%
disease were assigned a value of 2, mice with 61–80% disease were
assigned a value of 3, micewith 81–100% diseasewere assigned a value
of 4, andmicewithgreater than100%diseasewere assigned avalue of 5.
Values for all parameters were combined for each experimental set of
mice and graphed.Statistics
Prism (GraphPad; San Diego, CA) was used for all statistical tests of
signiﬁcance (P values of ≤ .05).Acknowledgments
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